Also compilation of basal cytokeratins (CK5/6 or CK14 or CK17 – positive vs. negative tumours) was not associated significantly with patient survival (hazard ratio 1.46, 95%CI 0.90–2.37, p = 0.127; log-rank p = 0.124) (Table 2, Fig. 2). This evidence concerns the gene KRT17 and neoplasm.